drugset / Trial / NCT00822107

A Translational Approach to Gitelman Syndrome

NCT00822107

NaSingle-groupOpen-labelDiagnostic

Summary

This study will test the response to a single dose of thiazide diuretic as a diagnostic test for Gitelman syndrome. Individuals with hypokalemic alkalosis will be enrolled. After a baseline study, they will have the response to 50 mg hydrochlorothiazide on fractional chloride excretion examined.

Timeline

Start
2009-01
Primary completion
2013-01
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrochlorothiazide Unknown 50 mg Oral

Indications